Skip to main content
. 2022 Mar 8;22:62. doi: 10.1186/s12906-022-03538-9

Table 6.

Clinical chemistry of male rats treated with GlucoMedix® at 28 days

Group/dose (mg/kg) GLU (mg/dL) T-Chol (mg/dL) TG (mg/dL) AST(U/L) ALT(U/L) BUN (mg/dL) Crea (mg/dL) TSH (mIU/L) T3(mIU/L) T4(ug/dL)
250 92.2 + 2.59 97.2 + 1.64 70.0 + 1.58 31.4 + 0.89 34.8 + 0.84 37.6 + 2.07 0.84 + 0.17 2.98 + 0.32 2.88 + 0.15 1.14 + 0.15
1000 90.4 + 1.52 92.8 + 4.15 67.4 + 1.52 29.4 + 1.14 33.2 + 2.59 37.2 + 1.64 0.64 + 0.11 2.88 + 0.31 2.68 + 0.16 1.02 + 0.13
2000 87.2 + 2.59 90.8 + 3.56 64.6 + 2.70 27.6 + 2.97 32.8 + 1.64 34.6 + 2.61 0.66 + 0.15 2.88 + 0.43 2.34 + 0.17 0.94 + 0.11
Control 90.0 + 1.58 94.2 + 3.19 65.4 + 3.51 28.2 + 2.86 35.2 + 2.77 35.6 + 3.36 0.80 + 0.07 2.82 + 0.41 2.44 + 0.18 1.04 + 0.13

Values are expressed as mean ± SD. n = 5. Parameters included: glucose (GLU), total cholesterol (T-Chol), triglycerides (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), creatinine (Crea), thyroid stimulating hormone (TSH), and thyroid hormones (T3, T4). No significant difference between the parameters compared to the control group